BMT CTN Protocol 1101

A Multi-Center, Phase III, Randomized Trial of Reduced Intensity(RIC) Conditioning and Transplantation of Double Unrelated Umbilical Cord Blood (dUCB) versus HLA-Haploidentical Related Bone Marrow (Haplo) for Patients with Hematologic Malignancies

            Protocol Co-Chair: Ephraim Fuchs, MD (410-955-8143) fuchsep@jhmi.edu

            Protocol Co-Chair: Paul O’Donnell, MD, PhD (206-667-1968) podonnel@fhcrc.org

            Protocol Co-Chair: Claudio Brunstein, MD (612-625-3918) bruns072@umn.edu

            Protocol Officer: Mary Eapen, MD  (414-805-0700) meapen@mcw.edu

            Protocol Coordinator: Jamie Garrison (301-251-1161) jgarrison@emmes.com

            Medical Monitor: Gabriella Meyers, MD meyersg@ohsu.edu

        

           

The BMT CTN is committed to including widespread transplant community participation in these trials. However, affiliate center applications are not currently being accepted for this study.